Calidi Biotherapeutics CLDI SEC Filings

NYSE CLDI
$0.64 -0.13 (-16.52%)
As of: Oct 22, 2026 · 3:59 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Calidi Biotherapeutics, Inc. (CLDI) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001493152-26-044381Sep 25, 2026 9:15 PM
28-KCurrent Report0001493152-26-043724Sep 22, 2026 9:00 PM
3424B5Prospectus0001493152-26-043156Sep 17, 2026 9:00 PM
44Insider Transaction0001493152-26-039292Aug 19, 2026 11:00 PM
54Insider Transaction0001493152-26-039290Aug 19, 2026 11:00 PM
64Insider Transaction0001493152-26-039291Aug 19, 2026 11:00 PM
74Insider Transaction0001493152-26-039289Aug 19, 2026 11:00 PM
84Insider Transaction0001493152-26-039288Aug 19, 2026 11:00 PM
94Insider Transaction0001493152-26-039287Aug 19, 2026 11:00 PM
104Insider Transaction0001493152-26-039286Aug 19, 2026 11:00 PM
114Insider Transaction0001493152-26-039285Aug 19, 2026 11:00 PM
1210-QQuarterly & Annual Report0001493152-26-037847Aug 13, 2026 5:01 PM
138-KCurrent Report0001493152-26-037840Aug 13, 2026 4:45 PM
148-KCurrent Report0001493152-26-035666Jul 31, 2026 9:00 PM
158-KCurrent Report0001493152-26-033594Jul 16, 2026 9:30 PM
163Insider Transaction0001493152-26-031118Jun 29, 2026 9:12 PM
178-KCurrent Report0001493152-26-029710Jun 23, 2026 12:30 PM
188-KCurrent Report0001493152-26-029374Jun 18, 2026 9:00 PM
19DEFA14AOthers0001493152-26-027516Jun 5, 2026 9:00 PM
208-KCurrent Report0001493152-26-026415May 29, 2026 9:00 PM
21SCHEDULE 13GBeneficial Ownership Report0001172661-26-002136May 15, 2026 3:10 PM
2210-QQuarterly & Annual Report0001493152-26-023140May 14, 2026 4:41 PM-
238-KCurrent Report0001493152-26-023094May 14, 2026 4:15 PM-
248-KCurrent Report0001493152-26-022024May 8, 2026 9:17 PM
258-KCurrent Report0001493152-26-022024May 8, 2026 9:17 PM
268-KCurrent Report0001493152-26-022024May 8, 2026 9:17 PM
27DEFA14AOthers0001493152-26-019636Apr 29, 2026 9:01 PM
28DEF 14AOthers0001493152-26-019617Apr 29, 2026 8:34 PM
29PRE 14AOthers0001493152-26-017935Apr 17, 2026 9:24 PM
308-KCurrent Report0001493152-26-014951Apr 2, 2026 9:00 PM
31SCHEDULE 13DBeneficial Ownership Report0002109116-26-000004Mar 31, 2026 8:58 PM
32SCHEDULE 13DBeneficial Ownership Report0002109116-26-000004Mar 31, 2026 8:58 PM
33SCHEDULE 13DBeneficial Ownership Report0002109116-26-000004Mar 31, 2026 8:58 PM
3410-KQuarterly & Annual Report0001493152-26-013242Mar 27, 2026 9:00 PM
358-KCurrent Report0001493152-26-013236Mar 27, 2026 8:58 PM
368-KCurrent Report0001493152-26-009701Mar 11, 2026 9:08 PM
37SCHEDULE 13DBeneficial Ownership Report0002109116-26-000003Mar 9, 2026 5:15 PM
38424B5Prospectus0001493152-26-009239Mar 9, 2026 1:38 AM
39424B5Prospectus0001493152-26-009027Mar 6, 2026 11:07 PM
40S-3MEFProspectus0001493152-26-009037Mar 5, 2026 2:59 AM
41SCHEDULE 13GBeneficial Ownership Report0001493152-26-005942Feb 10, 2026 7:08 PM
428-KCurrent Report0001493152-26-005840Feb 10, 2026 1:08 AM
43SCHEDULE 13GBeneficial Ownership Report0002109116-26-000002Feb 4, 2026 8:06 PM
448-KCurrent Report0001493152-26-004089Jan 29, 2026 10:54 PM
454Insider Transaction0001493152-25-028030Dec 16, 2025 12:37 AM
464Insider Transaction0001493152-25-028030Dec 16, 2025 12:37 AM
474Insider Transaction0001493152-25-028030Dec 16, 2025 12:37 AM
4810-QQuarterly & Annual Report0001493152-25-022372Nov 13, 2025 9:46 PM
498-KCurrent Report0001493152-25-022349Nov 13, 2025 9:30 PM
508-KCurrent Report0001493152-25-021418Nov 10, 2025 1:30 PM
...

Calidi Biotherapeutics, Inc. SEC Filings API

Pull Calidi Biotherapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=CLDI&formtype=10-K,10-Q&api_key=YOUR_API_KEY